First real-world study: Covaxin effectiveness 50%
2021-11-24
Two doses of Covaxin have 50 per cent effectiveness against symptomatic Covid-19, the first real-world assessment of the effectiveness of the vaccine developed in India suggests. The study, published in The Lancet Infectious Diseases journal, assessed 2,714 hospital workers at AIIMS, New Delhi, who were symptomatic and underwent RT-PCR testing for the coronavirus between April…Continue Reading